Validation and comparison of several published prognostic systems for patients with small cell lung cancer Source: Eur Respir J 2011; 38: 657-663 Year: 2011
Clinical and prognostic significance of autoantibodies against recoverin in non small cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 394s Year: 2003
KI67: Analysis of its expression and prognostic significance in a resected non small cell lung cancer population Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012
Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data Source: Eur Respir J 2015; 46: 1751-1761 Year: 2015
Assessing the relevance of biological prognostic indices in predicting survival in non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017
Analysis of surgical stage lung cancer and tumour markers prognostic value Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006
A practical measurement of thoracic sarcopenia: correlation with clinical parameters and outcomes in advanced lung cancer Source: ERJ Open Res 2016: 00085-2015 Year: 2016
The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients. Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019
Identification of genes with diagnostic and prognostic value in lung cancer. Source: International Congress 2019 – Biology of lung cancer Year: 2019
The prognostic value of the expression of GST-π in response to chemotherapy in cytological and pathological specimens of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 74s Year: 2002
Time in lung cancer diagnosis and its prognostic implication Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018
Composite anatomical–clinical–molecular prognostic model in nonsmall cell lung cancer Source: Eur Respir J 2011; 37: 136-142 Year: 2011
Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019
The prognostic significance of different clinical, radiological and laboratory parameters in sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 46s Year: 2003
Clinical significance of serum cathepsin K level during chemotherapy of lung cancer. Can we use it as a marker of small cell lung cancer? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Late-breaking abstract: Is primary tumour standardized uptake value (SUV) an independent prognostic factor for non small cell lung cancer (NSCLC)? A meta-analysis based on individual data Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features Source: Eur Respir J 2006; 28: Suppl. 50, 335s Year: 2006
Oxidant- antioxidant balance in lung cancer: is there any prognostic correlation? Source: Eur Respir J 2003; 22: Suppl. 45, 251s Year: 2003
A basic prediction model with clinical parameters to diagnose lung cancer. Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021